Special Issue "27th International Symposium on Hepatitis C Virus and Related Viruses"
Deadline for manuscript submissions: 30 September 2021.
Interests: Hepatitis C; viral immunology; liver immunology; liver fibrosis
This Special Issue is dedicated to the 27th International Symposium on Hepatitis C Virus and Related Viruses (HCV2020) that will be held in Montreal, Quebec, Canada, July 6–9 2020. This annual conference has been instrumental in developing and advancing major discoveries in the HCV field, including the understanding of the virus life cycle, and the development of in vitro replication systems and animal models that led to the development of direct acting antivirals (DAA) that have revolutionized HCV treatment. Key discoveries in understanding the immune response and pathogenesis of HCV presented at this meeting are now the basis for ongoing vaccine development and preclinical trials. Despite this progress, basic research on HCV remains at the forefront to drive HCV elimination efforts and reduce the morbidity and mortality of the disease. Research into vaccine development, HCV pathogenesis and liver cancer following DAA treatment, novel diagnostics, and sequencing approaches to track the evolution and transmission of HCV in at-risk populations are only some of the remaining key research questions. HCV2020 will focus on the main objective of HCV elimination by bringing together basic and clinical investigators to discuss the remaining challenges in the HCV field, as well as novel approaches toward this aim. Given the increased research interest and threat to public health imposed by related flaviviruses like zika and dengue, this year’s program will increase the integration of issues related to these infections. The following themes will be addressed:
- Tools for HCV elimination: diagnostics, sequencing and beyond
- Innate immunity/virus-host interaction
- Virus entry and replication
- Virus translation and assembly
- Adaptive immunity
- Liver inflammation, viral pathogenesis and carcinogenesis
- Animal models, organoids and replication systems
- Antivirals, challenges and new frontiers
Symposium participants are invited to contribute original research papers or reviews to this Special Issue of Viruses.
Prof. Dr. Naglaa H. Shoukry
Dr. Selena Sagan
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- hepatitis C
- innate Immunity
- virus entry
- virus replication
- virus translation
- virus assembly
- adaptive Immunity
- liver inflammation
- liver cancer
- animal Models